Mark Vickers

Professor Mark Vickers is a Chair in Applied Medicine at the University of Aberdeen's School of Medicine, Medical Sciences and Nutrition. With a medical degree from Oxford and Biochemistry training at Cambridge, he transitioned from clinical haematology training at Hammersmith, Reading, and John Radcliffe Hospitals to academic leadership, becoming a professor in 2008 and director of the Academic Transfusion Medicine Unit in 2010.

• Specializes in phagocytic recognition mechanisms using red blood cells as models
• Research links glycosylation motifs to hemolysis in sickle cell disease and malaria
• Develops cellular immunotherapies for post-transplant lymphoproliferative disease and cancer
• Active in convalescent plasma research for COVID-19

His work spans hematology, immunology, and infectious disease, with key publications on:

• Mannose exposure in erythrocyte clearance
• Siglec-15 as AML therapeutic target
• EBV immunotherapy optimization
• Vitamin D in immune homeostasis

Scientific contributions include:

• British Society for Haematology membership
• Fellow of Royal College of Pathologists
• Member of Royal College of Physicians

Current projects involve:

• Supervising PhD students on innate immunotherapeutics
• Collaborating with Edinburgh University, Imperial College, and King's College London
• Developing GMP-compliant EBV-specific cell banks